Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
about
Stem cells as cellular vehicles for gene therapy against glioblastomaMesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunitiesCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Sui generis: gene therapy and delivery systems for the treatment of glioblastomaImmunotherapeutic organoids: a new approach to cancer treatmentPre-exposure of human adipose mesenchymal stem cells to soluble factors enhances their homing to brain cancer.Antitumor Activity of a Mesenchymal Stem Cell Line Stably Secreting a Tumor-Targeted TNF-Related Apoptosis-Inducing Ligand Fusion Protein.Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitroCurrent status of gene therapy for brain tumors.Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas.Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenograftsThe Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor.Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating CellsProbe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo.The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyTherapeutic potential of mesenchymal stem cells in regenerative medicineTherapeutic strategies targeting cancer stem cellsDifferences between brainstem gliomas in juvenile and adult rats.TRAIL on trial: preclinical advances in cancer therapyHuman adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources.Downregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells.Use of genetically engineered stem cells for glioma therapy.Future directions of operative neuro-oncology.Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line.Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy.Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells.In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.Imaging of human mesenchymal stromal cells: homing to human brain tumors.Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.Gene Delivery in Neuro-Oncology.Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma.Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiologyComplete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma*.Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer.Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy.
P2860
Q26771835-6E69E975-F653-496E-8F2F-0B69551277C2Q26799013-388E65F2-5DF5-42CE-AE56-8D0E59C48846Q26830028-E216D2F3-450E-45D0-AAA9-BAFC1967C17EQ26850467-BAA890E8-FD0B-44D2-8EA8-853E555C3B94Q26853431-BCF336F4-8068-409A-A881-007095A54AF8Q30621190-8DFA6045-4AFE-4836-A6B5-090ACA955BFCQ33658976-0F643036-7398-41EA-AD59-C7F7DADDCE69Q33757933-B327D0F9-B972-45EA-BF0E-F0DFD62DE69BQ34318157-0009F826-F85B-435E-8E73-47A9FAFBC444Q34647951-A52D6270-FCB2-428D-82E8-65BC5A221F19Q35175677-640888AE-D0C3-48F8-9874-9C93DF939A8DQ35661609-28C37CCD-6694-4F23-B877-0B8B3BC7F407Q35664300-F616BAA1-9CA5-441A-947F-9E9E73720CE0Q36129857-ADC568EF-2C1A-41C2-A3AA-121BC772D021Q36312145-47281806-7348-49F7-9960-E8DEC2CC3548Q36644898-7A0F18FB-6B9C-47A2-9BBF-A7DF5013D0FFQ36737833-C8C474A8-67AC-43AB-99EA-CFB5EA9A2B44Q36887716-9DD477A1-6052-4212-84D1-14317CEF715AQ37093507-4E6B1102-9E7C-4FC8-80EE-284DF43D894EQ37433463-0789DE2E-01F9-46B6-B69F-329843C4161DQ37633231-1BB615ED-5DA0-408E-9345-B8C3D3F604BBQ38185498-26E989F6-1B39-49B0-9178-43ACEEA1077CQ38725336-AB30A68D-4A03-468C-A4EE-98B2E650B146Q38730790-61D165FF-15DE-4DAF-B6BB-980687776F43Q38801098-EA1CCF2C-AEB3-4A2E-98BA-5C9C75798922Q38827379-E3EA2300-AFCB-4B5E-A762-26B47780A150Q38869957-1C47F6E6-395A-436B-AF1D-AB3031BE4EBCQ39137400-D9426AF8-1489-4C2E-A789-81024D2580ACQ39140400-E6B42B94-6D8B-409F-9BBB-ECF3FF0FA76EQ39207599-E1596150-C8A6-4BF4-A797-F6F7B7CB61CAQ39379196-69E1EB52-CF39-4E0E-8DA9-E20915A05A14Q39443502-15C01474-5FE7-4CF4-ADD0-CC5F97BAB7C8Q39512141-8AE1828B-CC08-4B5D-BDDA-0BC9BD9161CDQ40060078-C0DC4A3C-42F6-4635-857B-3587E26122E0Q41109977-0D449A88-81D8-41AA-BF37-35E24A4A2834Q42284739-63FC3EBC-07F2-41ED-B230-3FD66A440683Q44763875-6703D400-952F-46F0-AFB4-90A5E4E3A436Q47109590-AA5649C6-EA51-431F-83F7-9F68EDDA7C5DQ47561992-BBD9859A-CDD3-4135-B525-9F3DA1AD5B73Q47707153-5804A99B-7C3C-4578-AFA7-1D2972FE2590
P2860
Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@ast
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@en
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@nl
type
label
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@ast
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@en
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@nl
prefLabel
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@ast
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@en
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic efficacy and safet ...... experimental brainstem glioma.
@en
P2093
Byung-Kyu Cho
Do-Hun Lee
Hee Won Jung
Ji Hoon Phi
Ji Yeoun Lee
Kyu-Chang Wang
Seung Ah Choi
Seung-Ki Kim
Sung-Kyun Hwang
P2860
P356
10.1093/NEUONC/NOQ147
P577
2010-11-09T00:00:00Z